Reduced intensity versus myeloablative allogeneic stem cell transplantation for the treatment of acute myeloid leukemia, myelodysplastic syndrome and acute …

ME Horwitz - Current opinion in oncology, 2011 - journals.lww.com
ME Horwitz
Current opinion in oncology, 2011journals.lww.com
The current retrospective data provide justification for the use of RIC regimens in all adult
stem cell transplant candidates with acute leukemia in remission and MDS. More definitive
conclusions regarding differences between the MAC and RIC approach to stem cell
transplantation await results of ongoing prospective randomized trials.
Summary
The current retrospective data provide justification for the use of RIC regimens in all adult stem cell transplant candidates with acute leukemia in remission and MDS. More definitive conclusions regarding differences between the MAC and RIC approach to stem cell transplantation await results of ongoing prospective randomized trials.
Lippincott Williams & Wilkins